0001209191-23-041343.txt : 20230705 0001209191-23-041343.hdr.sgml : 20230705 20230705194704 ACCESSION NUMBER: 0001209191-23-041343 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230701 FILED AS OF DATE: 20230705 DATE AS OF CHANGE: 20230705 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bender Jeremy CENTRAL INDEX KEY: 0001863107 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40431 FILM NUMBER: 231071599 MAIL ADDRESS: STREET 1: 395 OYSTER POINT BLVD. STREET 2: SUITE 217 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Day One Biopharmaceuticals, Inc. CENTRAL INDEX KEY: 0001845337 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 832415215 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY, SUITE 501 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 650 484-0899 MAIL ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY, SUITE 501 CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: Day One Biopharmaceuticals Holding Co LLC DATE OF NAME CHANGE: 20210209 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-07-01 0 0001845337 Day One Biopharmaceuticals, Inc. DAWN 0001863107 Bender Jeremy 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 1 1 0 0 Chief Executive Officer 0 Common Stock 2023-07-01 4 J 0 240288 0.00 D 939196 D Common Stock 2023-07-01 4 J 0 240288 0.00 A 240288 I By Melissa Claire Bender Common Stock 2023-07-01 4 G 0 240288 0.00 D 698908 D Common Stock 2023-07-01 4 G 0 240288 0.00 A 240288 I See Footnote Common Stock 2023-07-01 4 G 0 240288 0.00 D 0 I By Melissa Claire Bender Common Stock 2023-07-01 4 G 0 240288 0.00 A 240288 I See Footnote Common Stock 2023-07-01 4 G 0 59737 0.00 D 221837 I See Footnote Common Stock 2023-07-01 4 G 0 59737 0.00 A 300025 I See Footnote Common Stock 2023-07-01 4 G 0 29938 0.00 D 251636 I See Footnote Common Stock 2023-07-01 4 G 0 29938 0.00 A 270226 I See Footnote These shares were transferred as a division of marital property to the Reporting Person's spouse, Melissa Claire Bender. Represents shares of the Issuer's Common Stock that the Reporting Person transferred as a bona fide gift for no consideration. Represents shares held by The Jeremy Bender 2023 Grantor Retained Annuity Trust, dated June 27, 2023. Represents shares of the Reporting Person's spouse that were transferred as a bona fide gift for no consideration. Represents shares held by The Melissa Bender 2023 Grantor Retained Annuity Trust, dated June 27, 2023. Represents shares held by The Jeremy Bender 2022 Grantor Retained Annuity Trust that were transferred as a bona fide gift for no consideration. Represents shares held by The Jeremy Bender 2022 Grantor Retained Annuity Trust under Irrevocable Trust Agreement, dated March 29, 2022 of which the Reporting Person is trustee. Represents shares held by The Melissa Bender 2022 Grantor Retained Annuity Trust that were transferred as a bona fide gift for no consideration. Represents shares held by The Melissa Bender 2022 Grantor Retained Annuity Trust under Irrevocable Trust Agreement, dated March 29, 2022 of which the Reporting Person's spouse is trustee. /s/ Charles N. York II, Attorney-in-Fact 2023-07-05